imatge ciència



Gil MP, Whitaker R, Ding F, Tatar M, Helfand SL, Neretti N. 2014. Dietary switch reveals fast coordinated gene expression changes in Drosophila melanogaster.

Aging (Albany NY). 2014 May;6(5):355-68.

Gil M.P., Ding F., Franklin M., Ferreira J., Tatar M., Helfand S.L., Neretti N. 2014. Transcriptional response to dietary restriction in Drosophila melanogaster.

J Insect Physiol. 2014 May 10. pii: S0022-1910(14)00076-6. doi: 10.1016/j.jinsphys.2014.05.002. [Epub ahead of print]

Gil M.P., Ploquin M., Watford W., Lee S-H, Kim K., Wang X., Kanno Y., O'Shea J.J., Biron C.A. 2012. Regulating type 1 IFN effects in CD8 T cells during viral infections: changing STAT4 and STAT1 expression for function.

Blood. 120(18):3718-28.

Ikeda H., Gil M.P., Wang X., Louten J., Chu WM, Biron C.A. 2007. High Basal STAT4 Balanced by STAT1 Induction to Control Type 1 Interferon Effects in Natural Killer Cells.

Journal Experimental Medicine 204 (10) 2383-96 Epub 2007 Sep 10.

Brian K. Weaver B.K., Bohn E., Judd B.A., Gil M.P., Schreiber R.D. 2007. ABIN-3: a Molecular Basis for Species Divergence in Interleukin-10-Induced Anti-Inflammatory Actions.

Molecular and Cellular Biology, 27 (13), 4603-4616.

Gil M.P., Salomon R., Louten J., Biron C.A. 2006. Modulation of STAT1 protein levels, a mechanism shaping antiviral CD8 T cell responses.

Blood 2006 107 (3): 987-93. Epub 2005 Oct 6. An Inside Blood analysis of this article appeared in Blood 2006 107: 847-848.

Ramana C.V., Gil M.P., Han Y., Ransohoff R.M., Schreiber R.D., Stark G.R. 2001. Stat1- independent regulation of gene expression in response to IFNgamma.

Proc. Natl. Acad Sci.USA, 98(12), 6674-6679.

Gil M.P., Bohn E., Ramana C.V., O’Guinn A.K., Levine B., Virgin H.W., Stark G.R., Schreiber R.D. 2001. Biologic Consequences of Stat1-independent IFN signaling.

Proc. Natl. Acad Sci.USA, 98(12), 6680-6685.

Celada A., Gil P., McKercher S.R., Maki R.A. 1996. Identification of a transcription factor that binds to the S box of the I-A beta gene of the major histocompatibility complex.

Biochemical Journal, 313, 737-744.                                      

Barrera J.M., Bruguera M., Ercilla M.G., Gil C., Celis R., Gil M.P., Onorato M.V., Rodés J., Ordinas A. 1995. Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C.

Hepatology, 21, 639-644.                                                       

Barrera J.M., Bruguera M., Ercilla M.G., Sánchez-Tapias J.M., Gil M.P., Gil C., Costa J., Gelabert A., Rodés J., Castillo R. 1991. Incidence of Non-A Non-B Hepatitis after screening for antibodies to Hepatitis C Virus and surrogate markers.

Annals of Internal Medicine, 115, 596-600.                           

Sánchez-Tapias J.M.,Barrera J.M., Costa J., Ercilla M.G., Parés A., Comalrrena L., Soley F., Bruix J, Calvet X., Gil M.P., Mas A., Bruguera M., Castillo R., Rodés J. 1990. Hepatitis C virus infection in patients with non- alcoholic chronic liver disease.

Annals of Internal Medicine, 112, 921-924.                           


Reviews and Book Chapters

Gil M.P., Kumar A., Enelow R.I., Ramana C. V. Stat1 independent pathways in IFN signaling.

In :Interferons: Current Status. K..C.  Chadha ed. Research Signpost, Kerala, India, p. 55-67, 2007

Gil M.P., Ramana C.V., Schreiber R.D., Stark G.R. 2002. Stat1-dependent and -independent pathways in IFNgamma-dependent signaling. (Review)

Trends Immunol. 23(2), 96-101 

"Créixer amb Poe"
Brahe y Kepler